消除风疹的进展——世界卫生组织东南亚区域,2013-2021年
2013-2021年,世卫组织东南亚区域11国中6国引入含风疹疫苗,所有国家均已将含风疹疫苗纳入常规免疫;年报告风疹发病率从5.5例/百万降至1.1例/百万,下降80%;马尔代夫和斯里兰卡已验证消除风疹,不丹、朝鲜和东帝汶已阻断风疹病毒地方性传播超过36个月;区域取得实质进展,但需强化措施以实现消除。
要点
- 2013-2021年,6个东南亚区域国家引入含风疹疫苗,所有国家现已将含风疹疫苗纳入常规免疫。
- 风疹疫苗第一剂常规免疫覆盖率从2013年12%升至2021年86%,增幅超过600%。
- 年报告风疹发病率从5.5例/百万降至1.1例/百万,下降80%。
核心结论
- 东南亚区域在消除风疹方面取得实质进展,但需强化措施以实现消除。
研究设计与样本
- 本报告更新既往报告,描述2013-2021年世卫组织东南亚区域11国消除风疹的进展。
主要发现
- 2013-2021年,6个东南亚区域国家引入含风疹疫苗;所有区域国家现已在常规免疫中使用含风疹疫苗。
- 风疹疫苗第一剂常规免疫覆盖率从2013年12%升至2021年86%,增幅超过600%。
- 年报告风疹发病率从5.5例/百万人口降至1.1例/百万人口,下降80%。
- 马尔代夫和斯里兰卡已验证消除风疹;不丹、朝鲜和东帝汶已阻断风疹病毒地方性传播超过36个月。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
During 2013, the 11 countries of the World Health Organization (WHO) South-East Asia Region* (SEAR) adopted the goals of measles elimination and rubella and congenital rubella syndrome (CRS) control† by 2020. During 2019, SEAR countries declared a broader goal for eliminating both measles and rubella§ by 2023 (1). Before 2013, only five SEAR countries had introduced rubella-containing vaccine (RCV). This report updates a previous report and describes progress toward rubella elimination in SEAR during 2013-2021 (2). During 2013-2021, six SEAR countries introduced RCV; all countries in the Region now use RCV in routine immunization. Routine immunization coverage with the first dose of a rubella-containing vaccine (RCV1) increased >600%, from 12% during 2013 to 86% during 2021, and an estimated 515 million persons were vaccinated via RCV supplementary immunization activities (SIAs)¶ during 2013-2021. During this time, annual reported rubella incidence declined by 80%, from 5.5 to 1.1 cases per million population. Maldives and Sri Lanka are verified as having achieved rubella elimination; Bhutan, North Korea, and Timor-Leste have halted endemic transmission of rubella virus for >36 months. SEAR has made substantial progress toward rubella elimination; however, intensified measures are needed to achieve elimination.
引用
- Khanal S, Bahl S, Sangal L, et al. Progress Toward Rubella Elimination - World Health Organization South-East Asia Region, 2013-2021. MMWR Morb Mortal Wkly Rep. 2023. PMID: 37347708. doi:10.15585/mmwr.mm7225a2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。